Clinuvel Pharmaceuti
CUV
End-of-day quote AUSTRALIAN SECURITIES EXCHANGE LIMITED - 09/20
18.41AUD
-0.49%
Prev.18.4100
Open18.5000
High18.5700
Low18.3000
Volume43 290
Company
Clinuvel Pharmaceuticals Ltd. is a global biopharmaceutical company.It engages in the the development of SCENESSE, its proprietary photoprotective drug.It also offers drugs for the treatment of various skin disorders.The company was founded by Robert Thomas Dorr on December 14, 1999 and is...
Sector :
Biopharmaceuticals
Calendar :
2018-09-21 CLINUVEL PHARMACEUTICALS LIMITED : Ex-dividend day for final dividend
Latest news
09/21CLINUVEL PHARMACEUTICALS LIMITED : Ex-dividend day for final dividend
FA
09/20CLINUVEL PHARMACEUTICALS : NASDAQ Int Des Virtual Investor Conference Presentation
PU
09/11CLINUVEL PHARMACEUTICALS : Appendix 3B
PU
09/10CLINUVEL PHARMACEUTICALS : Investor Presentation NewsMakers Conference
PU
09/05CLINUVEL PHARMACEUTICALS : US FDA Update
PU
08/29CLINUVEL delivers second positive financial result
GL
08/29CLINUVEL PHARMACEUTICALS : Appendix 4E and Preliminary Financial Report
PU
08/21CLINUVEL PHARMACEUTICALS : Investor Summary
PU
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance18,518,520,5
Spread/Res.-0,49%-0,49%-10%
Spread/Supp.23%39%80%
Support15,013,310,2